Alliqua BioMedical to spin off and merge its Contract Manufacturing Business with TO Pharmaceuticals LLC to Create an Independent, Publicly Traded Company focused on Cannabinoid-Based Pharmaceutical Therapies Nov 28 2018, 7:30 AM EST
Alliqua BioMedical Inc. and Adynxx, Inc. Announce Merger Agreement to Create NASDAQ-listed Clinical-Stage Pharmaceutical Company with a Focus on Pain and Inflammation Oct 12 2018, 7:00 AM EDT
Alliqua BioMedical, Inc. Announces Definitive Asset Purchase Agreement with Celularity, Inc. Jan 5 2018, 4:30 PM EST
Alliqua BioMedical, Inc. Reports Third Quarter of Fiscal Year 2017 Financial Results and Increases Fiscal Year 2017 Financial Outlook Nov 9 2017, 7:02 AM EST
Alliqua BioMedical, Inc. Engages Cowen to Assist in Evaluating Potential Strategic Alternatives Nov 9 2017, 7:01 AM EST
Alliqua BioMedical, Inc. to Announce Third Quarter of Fiscal Year 2017 Results on November 9th Oct 30 2017, 4:05 PM EDT
Alliqua BioMedical, Inc. Announces the Sale of TheraBond® 3D Antimicrobial Barrier Systems Product Line; Alliqua Updates Fiscal Year Outlook Sep 5 2017, 7:30 AM EDT
